Change in Antimicrobial Therapy Based on Bronchoalveolar Lavage Data Improves Outcomes in ICU Patients with Suspected Pneumonia

Table 3

Outcome measures of patients based on implementation of BAL report-directed antimicrobial modification.

	Antimicrobial modified		value
	Yes (n = 113)	No (n = 37)
Duration-related outcomes
Total duration of hospital stay (median, (IQR))	16 (12–25)	20 (15–37)	0.042
Total duration of ICU stay (median, (IQR))	10 (7–15)	15 (10–30)	0.003
Duration from admission to FB (median, (IQR))	6 (3–10)	7 (5–11)	0.502
Duration from FB to discharge from ICU (median, (IQR))	6(3–10)	7(5–11)	0.111
Duration from FB to discharge from hospital (median, (IQR))	6 (4–10)	8 (5–13)	0.064
Clinical outcomes
Expired, n (%)	23 (20.4)	12 (32.4)
Improved, n (%)	82 (72.5)	18 (48.7)	0.018^#
Unchanged, n (%)	8 (7.1)	7 (18.9)

Mann–Whitney U test; ^#chi-square test; IQR: interquartile range.